A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted in favor of authorizing Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout. The FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires a single shot. The panel consisting of doctors, infectious disease experts and medical researchers voted unanimously that the benefits of the vaccine outweigh its risks in people age 18 and over. J&J has said it will be able to ship three million to four million doses of its vaccine next week if it receives the emergency use authorization (EUA), as expected. Senior White House adviser Andy Slavitt announced on Twitter that the FDA would meet to finalize the EUA on Saturday. …
Read More
RSS Feed | The Epoch Times
